RxDoctor Payments Data

Ali Mortazavi, MD

Clinical Cardiac Electrophysiology · Houston, TXNPI 1295821478

Payments from drug & device makers

What this record shows

5 manufacturers reported payments, led by Abbott at 34.9% of the total. Reporting peaked in 2023 at $2,086 and has fallen 61.1% since, to $812 in 2025. That places this record below the midpoint for clinical cardiac electrophysiology clinicians in TX, where the typical reported total is $27,892.

$6,536in general payments, 2019–2025

Across 160 payments — averaging $40.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$2K
  • Edwards Lifesciences$2K
  • Boston Scientific$1K
  • Medtronic$730
  • Avinger Inc.$24
$8,858in research payments, 2019–2025

Across 5 payments — averaging $1771.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Boston Scientific$9K

What the payments were for

  • Travel & lodging$3,88859%
  • Food & beverage$2,64841%

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Abbott26$2,278
Edwards Lifesciences122$2,015
Boston Scientific6$1,489
Medtronic5$730
Avinger Inc.1$24

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,536 in reported general payments places this provider in the 15th percentile of 233 clinical cardiac electrophysiology providers in Texas.

See all clinical cardiac electrophysiology providers in Texas →

Medicare billing

Part B allowed, 2024
$5,041
Medicare patients
14
Services billed
43

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban331$252,209
EntrestoSacubitril/Valsartan64$53,934
XareltoRivaroxaban28$28,372
Atorvastatin Calcium426$13,196
Rosuvastatin Calcium211$9,379
ClopidogrelClopidogrel Bisulfate386$8,857
Ezetimibe50$6,826
Metoprolol Succinate263$6,520
Carvedilol354$5,809
Losartan Potassium215$4,318
Amiodarone Hcl153$2,958
Metoprolol Tartrate292$2,870
Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide47$2,003
Lisinopril172$1,858
Minocycline Hcl193$1,546

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in Houston

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →